Cannabis Report
Home > Boards > US Listed > Biotechs > Pluristem Therapeutics, Inc. (PSTI)

the gamble is NOT on twins piss poor leadership.....

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
bluehorsesho Member Profile
 
Followed By 17
Posts 3,077
Boards Moderated 0
Alias Born 12/17/13
160x600 placeholder
Pluristem Signs Collaboration Agreement With Thermo Fisher Scientific GlobeNewswire Inc. - 7/9/2018 7:00:00 AM
Pluristem and Fukushima University Report Positive Data: PLX-R18 Increases Survival Rates and Mitigates Severe Intestinal Dam... GlobeNewswire Inc. - 6/25/2018 7:00:00 AM
U.S. Department of Defense to Study Pluristem’s PLX-R18 for the Treatment of Mustard Gas Injuries GlobeNewswire Inc. - 6/19/2018 7:00:00 AM
Pluristem to Open Weekly Market Trading at TASE Following Positive Study Results GlobeNewswire Inc. - 6/14/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2018 4:00:44 PM
Pluristem Reports Positive Top-Line Results from Its Multinational Phase II Intermittent Claudication Study GlobeNewswire Inc. - 6/12/2018 6:00:00 AM
Pluristem to Announce Top-Line Results of Its Multinational Phase II Intermittent Claudication Study on June 12, 2018 GlobeNewswire Inc. - 6/4/2018 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/31/2018 4:06:46 PM
Pluristem Reports Third Quarter Fiscal 2018 Corporate and Financial Highlights GlobeNewswire Inc. - 5/10/2018 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2018 4:15:41 PM
U.S. FDA Clears Pluristem’s IND to Treat Victims Exposed to Acute Radiation GlobeNewswire Inc. - 5/2/2018 9:15:07 AM
U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery GlobeNewswire Inc. - 4/25/2018 7:00:00 AM
Pluristem and Indiana University to Initiate Joint Project Evaluating PLX-R18 in Acute Radiation Syndrome, Targeting Bridging... GlobeNewswire Inc. - 4/23/2018 7:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/3/2018 4:33:38 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/3/2018 4:13:19 PM
Roger Jeffs, Former Co-CEO of United Therapeutics, Joins Pluristem's Strategic Advisory Board GlobeNewswire Inc. - 3/26/2018 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/19/2018 5:09:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/15/2018 5:16:57 PM
Pluristem’s PLX-R18 Improves Hematopoietic Transplantation as Reported in Scientific Journal Frontiers in Medicine GlobeNewswire Inc. - 2/27/2018 7:00:00 AM
Pluristem Issues Letter to Shareholders GlobeNewswire Inc. - 2/7/2018 7:44:38 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 2/6/2018 4:22:26 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/6/2018 4:08:38 PM
Pluristem’s PLX Cells Significantly Inhibit Cancer Cell Growth in Newly Published Study GlobeNewswire Inc. - 1/12/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/9/2018 4:04:55 PM
FDA Clears Pluristem’s Expanded Access Program to Initiate Treatments of Critical Limb Ischemia Outside of Ongoing Phase II... GlobeNewswire Inc. - 1/9/2018 7:00:00 AM
bluehorsesho   Thursday, 12/07/17 07:26:08 PM
Re: None
Post # of 13940 
the gamble is NOT on twins piss poor leadership.....

it's on the validation by the US Government.....IF it hits and they order......well then.....I will send the twins.....a box of Cadbury chocolates and we go to 10 EASY......


I do Thank all the Hard workers BEHIND the scenes while these puppets take the credit for all your hard work and innovation.....

get Rid of these figure heads......IMHOP...it's not the right look a successful company needs....IMHOP

they are WAY over their heads......IMHOP

Look at what Alabama is now with Nick Saban......


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist